• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌根治性切除术后围手术期输血与生存时间之间无相关性。

Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer.

作者信息

Moriguchi S, Maehara Y, Akazawa K, Sugimachi K, Nose Y

机构信息

Department of Medical Informatics, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

出版信息

Cancer. 1990 Dec 1;66(11):2331-5. doi: 10.1002/1097-0142(19901201)66:11<2331::aid-cncr2820661113>3.0.co;2-h.

DOI:10.1002/1097-0142(19901201)66:11<2331::aid-cncr2820661113>3.0.co;2-h
PMID:2245388
Abstract

To better comprehend the relationship between perioperative blood transfusion and survival time after curative gastrectomy for advanced gastric cancer, the authors reviewed retrospectively data on 568 patients treated in their clinics from 1965 to 1983. Of these 568, 195 (34.3%) required no blood transfusion and 373 (65.7%) required transfusions within the perioperative period. Univariate analysis indicated that the survival time of the transfusion recipients was significantly less than that of the patients who had no transfusions (P less than 0.01). In subgroups of the authors' patients stratified to adjust for stage of disease, there was, however, no significant difference between the survival rates. Subsequently, multivariate analysis, using the Cox regression analysis, which adjusted for sex, age, and other covariates, indicated that perioperative blood transfusion was not a useful factor for predicting survival time. Multivariate analysis suggested that tumor size (P less than 0.01), degree of invasion into the gastric wall (P less than 0.01) and status of lymph node metastasis (P less than 0.01) were the most important covariates after curative gastrectomy for advanced gastric cancer. The authors' findings revealed the lack of any relationship between perioperative blood transfusion and survival time of patients who underwent curative resection for advanced gastric cancer.

摘要

为了更好地理解进展期胃癌根治性胃切除术后围手术期输血与生存时间之间的关系,作者回顾性分析了1965年至1983年在其诊所接受治疗的568例患者的数据。在这568例患者中,195例(34.3%)不需要输血,373例(65.7%)在围手术期需要输血。单因素分析表明,输血患者的生存时间明显短于未输血患者(P<0.01)。然而,在作者根据疾病分期分层的患者亚组中,生存率之间没有显著差异。随后,使用Cox回归分析进行多因素分析,对性别、年龄和其他协变量进行校正,结果表明围手术期输血不是预测生存时间的有用因素。多因素分析表明,肿瘤大小(P<0.01)、胃壁浸润程度(P<0.01)和淋巴结转移状况(P<0.01)是进展期胃癌根治性胃切除术后最重要的协变量。作者的研究结果显示,进展期胃癌根治性切除患者的围手术期输血与生存时间之间不存在任何关联。

相似文献

1
Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer.胃癌根治性切除术后围手术期输血与生存时间之间无相关性。
Cancer. 1990 Dec 1;66(11):2331-5. doi: 10.1002/1097-0142(19901201)66:11<2331::aid-cncr2820661113>3.0.co;2-h.
2
Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses.
Cancer. 1991 Jun 15;67(12):3006-9. doi: 10.1002/1097-0142(19910615)67:12<3006::aid-cncr2820671213>3.0.co;2-v.
3
Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative.围手术期输血对胃癌切除术后复发和生存的影响:来自美国胃癌协作组的 7 个机构对 765 例患者的分析。
J Am Coll Surg. 2015 Sep;221(3):767-77. doi: 10.1016/j.jamcollsurg.2015.06.012. Epub 2015 Jun 21.
4
Association of perioperative allogeneic blood transfusions and prognosis of patients with gastric cancer after curative gastrectomy.围手术期异体输血与胃癌根治性切除术后患者预后的相关性
Am J Surg. 2014 Jul;208(1):80-7. doi: 10.1016/j.amjsurg.2013.08.029. Epub 2013 Oct 23.
5
Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database.围手术期输血对胃癌患者预后的影响:单中心数据库的回顾性分析。
BMC Cancer. 2018 Jun 11;18(1):649. doi: 10.1186/s12885-018-4574-4.
6
Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.围手术期异体输血对II/III期胃癌患者的不良预后影响。
Gastric Cancer. 2016 Jan;19(1):255-63. doi: 10.1007/s10120-014-0456-x. Epub 2015 Jan 7.
7
Blood transfusions and results after curative resection for gastric cancer.胃癌根治性切除术后的输血情况及结果
Suppl Tumori. 2003 Sep-Oct;2(5):S27-30.
8
Does perioperative blood transfusion influence long-term prognosis of gastric cancer?围手术期输血是否会影响胃癌的长期预后?
Dig Dis Sci. 1997 Oct;42(10):2072-6. doi: 10.1023/a:1018818517811.
9
Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.日本胃癌患者外科治疗的时间趋势及预后
Br J Cancer. 2000 Oct;83(8):986-91. doi: 10.1054/bjoc.2000.1427.
10
[Analysis of risk factor of perioperative complications in patients with radical gastrectomy for gastric cancer and its influence on prognosis].[胃癌根治术患者围手术期并发症的危险因素分析及其对预后的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Jan 25;21(1):53-60.

引用本文的文献

1
Blood transfusion might not be recommended for gastric cancer patients with pretransfusion minimum hemoglobin values higher than 90 g/l: a real-world study covering 20 years of 13 470 patients.对于输血前最低血红蛋白值高于90g/l的胃癌患者,可能不建议输血:一项涵盖13470例患者20年的真实世界研究。
Int J Surg. 2024 Nov 1;110(11):7020-7033. doi: 10.1097/JS9.0000000000001535.
2
Effects of perioperative blood transfusion in gastric cancer patients undergoing gastrectomy: A systematic review and meta-analysis.胃癌患者胃切除术中围手术期输血的影响:一项系统评价和荟萃分析。
Front Surg. 2023 Jan 17;9:1011005. doi: 10.3389/fsurg.2022.1011005. eCollection 2022.
3
Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database.
围手术期输血对胃癌患者预后的影响:单中心数据库的回顾性分析。
BMC Cancer. 2018 Jun 11;18(1):649. doi: 10.1186/s12885-018-4574-4.
4
Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.肾上腺皮质癌切除术后输血与生存情况:来自美国肾上腺皮质癌研究组的一项研究
Am Surg. 2017 Jul 1;83(7):761-768.
5
Perioperative transfusion of leukocyte depleted blood products in gastric cancer patients negatively influences oncologic outcome: A retrospective propensity score weighted analysis on 610 curatively resected gastric cancer patients.胃癌患者围手术期输注去白细胞血液制品对肿瘤学结局有负面影响:对610例接受根治性切除的胃癌患者进行的回顾性倾向评分加权分析。
Medicine (Baltimore). 2016 Jul;95(29):e4322. doi: 10.1097/MD.0000000000004322.
6
Impact of Perioperative Blood Transfusion on Postoperative Complications and Prognosis of Gastric Adenocarcinoma Patients with Different Preoperative Hemoglobin Value.围手术期输血对不同术前血红蛋白值的胃腺癌患者术后并发症及预后的影响
Gastroenterol Res Pract. 2016;2016:6470857. doi: 10.1155/2016/6470857. Epub 2015 Dec 27.
7
Perioperative Allogenenic Blood Transfusion is Associated With Worse Clinical Outcome for Patients Undergoing Gastric Carcinoma Surgery: A Meta-Analysis.围手术期异体输血与胃癌手术患者更差的临床结局相关:一项荟萃分析。
Medicine (Baltimore). 2015 Sep;94(39):e1574. doi: 10.1097/MD.0000000000001574.
8
Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.围手术期异体输血对II/III期胃癌患者的不良预后影响。
Gastric Cancer. 2016 Jan;19(1):255-63. doi: 10.1007/s10120-014-0456-x. Epub 2015 Jan 7.
9
Impact of intraoperative blood loss on survival after curative resection for gastric cancer.术中出血量对胃癌根治性切除术后生存的影响。
World J Gastroenterol. 2013 Sep 7;19(33):5542-50. doi: 10.3748/wjg.v19.i33.5542.
10
SPan-1 is a useful prognostic marker for patients with stage IV gastric cancer who underwent palliative gastrectomy: a retrospective multivariate study.SPan-1 是一个有用的预后标志物,可用于接受姑息性胃切除术的 IV 期胃癌患者:一项回顾性多变量研究。
World J Surg. 2013 Jul;37(7):1681-7. doi: 10.1007/s00268-013-2016-7.